Weight-Loss drug may also help curb drinking, new study suggests
NCT ID NCT06546384
Summary
This study is testing if a medication called semaglutide, which is used for weight loss and diabetes, can also help people with obesity and fatty liver disease drink less alcohol or stop drinking altogether. Researchers will compare two groups: one group will receive the medication plus counseling, and the other will receive counseling alone. The main goal is to see if the medication leads to more people achieving complete abstinence from alcohol over 16 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospital Bern
Bern, 3010, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.